Herpes zoster occurred when the suppressive ability of immune system failed to prevent the reactivation of initial varicella-zoster virus infection. Its frequency is higher among immune compromised individuals. Herpes zoster presents with characteristic painful grouped vesicles on erythematous background along the dermatome area and could be complicated by post-herpetic neuralgia. The current review examined the risk factors and discussed herpes zoster in different situations, treatment and concluded by discussing the future research trend of herpes zoster.
Tyndall, M.W., Nasio, J., Agoki, E., Malisa, W., Ronald, A.R., Ndinya-Achola, J.O., et al. (1995) Herpes Zoster as the Initial Presentation of Human Immunodeficiency Virus Type 1 Infection in Kenya. Clinical Infectious Diseases, 21, 1035-1037. https://doi.org/10.1093/clinids/21.4.1035
Wellar, T.H., Wetton, H.M. and Bell, E.J. (1958) The Etiological Agent of Varicella and Herpes Zoster: Isolation, Propagation and Cultural Characteristics in Vitro. Journal of Experimental Medicine, 108, 843-868. https://doi.org/10.1084/jem.108.6.843
Gnann, J.W. and Whitley, R.J. (2002) Herpes Zoster. New England Journal of Medicine, 347, 340-346. https://doi.org/10.1056/NEJMcp013211
Cohen, J.I. (2013) Clinical Practice: Herpes Zoster. New England Journal of Medicine, 369, 255e63.
Staikov, I., Neykov, N., Marinovic, B., Lipozencic, J. and Tsankov, N. (2014) Herpes Zoster as a Systemic Disease. Clinics in Dermatology, 32, 424-429. https://doi.org/10.1016/j.clindermatol.2013.11.010
Colebunders, R., Mann, J.M., Francis, H., Hila, K., Izaley, L., Iwaya, M., et al. (1988) Herpes Zoster in African Patients: A Clinical Predictor of Human Immunodeficiency Virus Infection. Journal of Infectious Diseases, 157, 314-318. https://doi.org/10.1093/infdis/157.2.314
Prescott, L.M., Harley, J.P. and Klein, D.A. (2002) Human Diseases Caused by Virus. Microbiology. 5th Edition, McGraw Hill, New York, 870-898.
Stevens, J.G. (1989) Human Herpes Viruses: A Consideration of the Latent State. Microbiological Reviews, 53, 318-332.
Cohen, J.I., Brunell, P.A., Straus, S.E. and Krause, P.R. (1999) Recent Advances in Varicella-Zoster Virus Infection. Annals of Internal Medicine, 130, 922-932. https://doi.org/10.7326/0003-4819-130-11-199906010-00017
Steiner, I., Kennedy, P.G. and Pachner, A.R. (2007) The Neurotropic Herpes Viruses: Herpes Simplex and Varicella Zoster. Lancet Neurology, 6, 1015-1028. https://doi.org/10.1016/S1474-4422(07)70267-3
Donahue, J.G., Chao, P.W., Manson, J.E. and Plat, R. (1995) The Incidence of Zoster. Archives of Internal Medicine, 155, 1605-1609. https://doi.org/10.1001/archinte.1995.00430150071008
Ragozzino, M.W., Melton 3rd, L.J., Kurland, L.T., Chu, C.P. and Perry, H.O. (1982) Population-Based Study of Herpes Zoster and Its Sequelae. Medicine, 61, 310-316. https://doi.org/10.1097/00005792-198209000-00003
Buchinder, S.P., Katz, M.H., Hessel, N.A., et al. (1992) Herpes Zoster and Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases, 166, 1153-1156. https://doi.org/10.1093/infdis/166.5.1153
Naveen, K.N., Tophakane, R.S., Hanumanthayya, K., Pv, B. and Pai, V.V. (2011) A Study of HIV Seropositivity with Various Clinical Manifestation of Herpes Zoster among Patients from Karnataka, India. Dermatology Online Journal, 17, 3.
Dehne, K.L., Dhlakama, D.G., Richter, C., Mawadza, M., McClean, D. and Huss, R. (1992) Herpes Zoster as an Indicator of HIV Infection in Africa. Tropical Doctor, 22, 68e70. https://doi.org/10.1177/004947559202200207
Dahl, H., Marcoccia, J. and Linde, A. (1997) Antigen Detection: The Method of Choice in Comparison with Virus Isolation and Serology for Laboratory Diagnosis of Herpes Zoster in Human Immunodeficiency Virus-Infected Patient. Journal of Clinical Microbiology, 35, 345-349.
Gilden, D.H., Kleinschmidt-DeMaster, B.K., LaGuardia, J.J., Mahalingam, R. and Cohrs, R.J. (2000) Neurologic Complications of the Reactivation of Varicella-Zoster Virus. The New England Journal of Medicine, 342, 635-645. https://doi.org/10.1056/NEJM200003023420906
Harding, S.P., Lipton, J.R. and Wells, J.C. (1987) Natural History of Herpes Zoster Ophthalmicus: Predictors of Postherpetic Neuralgia and Ocular Involvement. British Journal of Ophthalmology, 71, 353-358. https://doi.org/10.1136/bjo.71.5.353
Shaikh, S. and Ta, C.N. (2002) Evaluation and Management of Herpes Zoster Ophthalmicus. American Family Physician, 66, 1723-1730.
Oxman, M.N., Levin, M.J., Johnson, G.R., et al. (2005) A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. The New England Journal of Medicine, 352, 2271-2284. https://doi.org/10.1056/NEJMoa051016
Choo, P.W., Galil, K., Donahue, J.G., Walker, A.M., Spiegelman, D. and Platt, R. (1997) Risk Factors for Postherpetic Neuralgia. Archives of Internal Medicine, 157, 1217-1224. https://doi.org/10.1001/archinte.1997.00440320117011
Gnann, J.W. and Whitley, R.J. (1991) Natural History and Treatment of Varicella-Zoster Virus in High-Risk Populations. Journal of Hospital Infection, 18, 317-329.
Ormerod, L.D., Larkin, J.A., Margo, C.A., et al. (1998) Rapidly Progressive Herpetic Retinal Necrosis: A Blinding Disease Characteristic of Advanced AIDS. Clinical Infectious Diseases, 26, 34-45. https://doi.org/10.1086/516285
Thomas, S.L. and Hall, A.J. (2004) What Does Epidemiology Tell Us about Risk Factors for Herpes Zoster? The Lancet Infectious Diseases, 4, 26-33.
Forbes, H.J., Bhaskaran, K., Thomas, S.L., Smeeth, L., Clayton, T. and Langan, S.M. (2014) Quantification of Risk Factors for Herpes Zoster: Population Based Case-Control Study. BMJ, 348, g2911. https://doi.org/10.1136/bmj.g2911
Liu, B., Heywood, A.E., Reekie, J., Banks, E., Kaldor, J.M., MacIntyre, P., et al. (2015) Risk Factors for Herpes Zoster in a Large Cohort of Unvaccinated Older Adults: A Prospective Cohort Study. Epidemiology & Infection, 13, 2871-2881.
Onunu, A.N. and Uhunmwangho, A. (2004) Clinical Spectrum of Herpes Zoster in HIV-Infected versus Non-HIV Infected Patients in Benin City, Nigeria. West African Journal of Medicine, 23, 300-304.
Hira, S.K. (1996) Clinical Profile of HIV 1/2 Infection in Mumbai. Proceedings of the National Conference on HIV/AIDS Medicine, Pune, 23-24 November 1996, 35-39.
Friedman Kien, A.E., Lafleur, F.L., Gandler, E., et al. (1986) Herpes Zoster: A Possible Early Clinical Sign for Development of AIDS in High-Risk Individual. Journal of the American Academy of Dermatology, 14, 1023-1028. https://doi.org/10.1016/S0190-9622(86)70127-8
Melbye, M., Grossman, R.J., Goedert, J.J., et al. (1987) AIDS after Herpes Zoster. The Lancet, 316, 156-157.
Moss, A.R., Bacchett, P., Osmond, D., et al. (1988) Seropositivity for HIV and Development of AIDS or AIDS-Related Condition. Three Years Follow up of San Francisco Hospital Cohort. British Medical Journal, 296, 745-750. https://doi.org/10.1136/bmj.296.6624.745
Highet, A.S. and Kurtz, J. (1992) Viral Infections. In: Champion, R.H., Burton, J.L. and Ebling, F.J.G., Eds., Textbook of Dermatology, 5th Edition, Blackwell Scientific Publication, Oxford, 925.
Meer, S., Coleman, H., Altini, M. and Alexander, T. (2006) Mandibular osteomyelitis and Tooth Exfoliation Following Zoster-CMV Co-Infection. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 101, 70-75. https://doi.org/10.1016/j.tripleo.2005.06.022
Glesby, M.J., Hoover, D.R., Tan, T., et al. (2004) Herpes Zoster in Women with and at Risk for HIV: Data from the Women’s Interagency HIV Study. Journal of Acquired Immune Deficiency Syndromes, 37, 1604-1609. https://doi.org/10.1097/00126334-200412150-00013
Weinberg, A., Wiznia, A.A., LaFleur, B.J., Shah, S. and Levin, M.J. (2004) Varicella-Zoster Virus-Specific Cell-Mediated Immunity in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases, 190, 267-270. https://doi.org/10.1086/422011
Levin, M.J., Anderson, J.P., Seage, G.R. and Williams, P.L. (2009) Short-Term and Long-Term Effects of Highly Active Antiretroviral Therapy on the Incidence of Herpes Zoster in HIV-Infected Children. Journal of Acquired Immune Deficiency Syndromes, 50, 182-191. https://doi.org/10.1097/QAI.0b013e31819550a4
French, M.A., Lenzo, N., John, M., Mallal, S.A., McKinnon, E.J., James, I.R., Price, P., Felxman, J.P. and Tay-Kearney, M.L. (2000) Immune Restoration Disease after the Treatment of Immunodeficient HIV-Infected Patients with Highly Active Antiretroviral Therapy. HIV Medicine, 1, 107-115. https://doi.org/10.1046/j.1468-1293.2000.00012.x
Espinosa, E., Peña-Jiménez, A., Ormsby, C.E., Vega-Barrientos, R. and Reyes-Terán, G. (2009) Later Onset of Herpes Zoster-Associated Immune Reconstitution Inflammatory Syndrome. HIV Medicine, 10, 454-457. https://doi.org/10.1111/j.1468-1293.2009.00700.x
Lawn, S.D., Bekker, L.G. and Miller, R.F. (2005) Immune Reconstitution Disease Associated with Mycobacterial Infections in HIV-Infected Individuals Receiving Antiretrovirals. The Lancet Infectious Diseases, 5, 361-373. https://doi.org/10.1016/S1473-3099(05)70140-7
Gebo, K.A., Kalyani, R., Moore, R.D. and Polydefkis, M.J. (2005) The Incidence of, Risk Factors for, and Sequelae of Herpes Zoster among HIV Patients in the Highly Active Antiretroviral Therapy Era. Journal of Acquired Immune Deficiency Syndromes, 40, 169-174. https://doi.org/10.1097/01.qai.0000178408.62675.b0
Lawn, S.D. and Wood, R. (2010) Immune Reconstitution Inflammatory Syndrome. The Lancet Infectious Diseases, 10, 833-834. https://doi.org/10.1016/S1473-3099(10)70280-2
Tsang, C.S. and Samaranayake, L.P. (2010) Immune Reconstitution Inflammatory Syndrome after Highly Active Antiretroviral Therapy: A Review. Oral Diseases, 16, 248-256. https://doi.org/10.1111/j.1601-0825.2009.01628.x
Rodgers, S. and Leslie, K.S. (2011) Skin Infection in HIV-Infected Individuals in the Era of HAART. Current Opinion in Infectious Diseases, 24, 124-129. https://doi.org/10.1097/QCO.0b013e328342cb31
Choi, W.R., et al. (2012) Herpes Zoster Immune Reconstitution Inflammatory Syndrome in a HIV-Infected Patient. Infection & Chemotherapy, 44, 391-394. https://doi.org/10.3947/ic.2012.44.5.391
Srikantiah, P., Walusimbi, M.N., Kayanja, H.K., Mayanja-Kizza, H., Mugerwa, R.D., Lin, R., Charlebois, E.D., Boom, W.H., Whalen, C.C. and Havlir, D.V. (2007) Early Virological Response of Zidovudine/Lamivudine/Abacavir for Patients Co-Infected with HIV and Tuberculosis in Uganda. AIDS, 21, 1972-1974. https://doi.org/10.1097/QAD.0b013e32823ecf6e
Shelburne, S.A., Visnegarwala, F., Darcourt, J., Graviss, E.A., Giordano, T.P., White, A.C. and Hamill, R.J. (2005) Incidence and Risk Factors for Immune Reconstitution Syndrome during Highly Active Antiretroviral Therapy. AIDS, 19, 399-406. https://doi.org/10.1097/01.aids.0000161769.06158.8a
Feller, L., Wood, N.H. and Lemmer, J. (2007) Herpes Zoster Infection as an Immune Reconstitution Inflammatory Syndrome in HIV-Seropositive Subjects: A Review. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 104, 455-460. https://doi.org/10.1016/j.tripleo.2007.02.001
Domingo, P., Torres, O.H., Ris, J. and Vazquez, G. (2001) Herpes Zoster as an Immune Reconstitution Disease after Initiation of Combination Antiretroviral Therapy in Patients with Human Immunodeficiency Virus Type-1 Infection. American Journal of Medicine, 110, 605-609. https://doi.org/10.1016/S0002-9343(01)00703-3
Naumann, G., Gass, J.D. and Font, R.L. (1968) Histopathology of Herpes Zoster Ophthalmicus. American Journal of Ophthalmology, 65, 533-541. https://doi.org/10.1016/0002-9394(68)93869-5
Goh, C.L. and Khoo, L. (1997) A Retrospective Study of the Clinical Presentation and Outcome of Herpes Zoster in a Tertiary Dermatology Outpatient Referral Clinic. International Journal of Dermatology, 36, 667-672. https://doi.org/10.1046/j.1365-4362.1997.00241.x
Cobo, M., Foulks, G.N., Liesegang, T., Lass, J., Sutphin, J., Wilhelmus, K., et al. (1987) Observations on the Natural History of Herpes Zoster Ophthalmicus. Current Eye Research, 6, 195-199. https://doi.org/10.3109/02713688709020090
Burgoon, C.F., Burgoon, J.S. and Baldridge, G.D. (1957) The Natural History of Herpes Zoster. JAMA, 174, 265. https://doi.org/10.1001/jama.1957.02980030041010
Sandor, E.V., Millman, A., Croxson, T.S. and Mildvan, D. (1986) Herpes Zoster Ophthalmicus in Patients at Risk for the Acquired Immune Deficiency Syndrome (AIDS). American Journal of Ophthalmology, 101, 153-155. https://doi.org/10.1016/0002-9394(86)90585-4
Baratz, K.H., Goins, K. and Cobo, M. (1988) Varicella-Zoster Viral Infections. In: Kaufman, H.E., Ed., The Cornea, Churchill Livingstone, New York, 279-298.
Arffa, R.C. (1997) Viral Diseases. In: Arffa, R.C. and Grayson, M., Eds., Grayson’s Diseases of the Cornea, 4th Edition, Mosby, St. Louis, 675-676.
Liesegang, T.J. (1985) Corneal Complications from Herpes Zoster Ophthalmicus. Ophthalmology, 92, 316-324. https://doi.org/10.1016/S0161-6420(85)34034-4
Womack, L.W. and Liesegang, T.J. (1983) Complications of Herpes Zoster Ophthalmicus. Archives of Ophthalmology, 101, 42-45. https://doi.org/10.1001/archopht.1983.01040010044004
Smith, J.B. and Fenske, N.A. (1995) Herpes Zoster and Internal Malignancy. The Southern Medical Journal, 88, 1089-1092. https://doi.org/10.1097/00007611-199511000-00001
Anderson, L.A., Landgren, O. and Engels, E.A. (2009) Common Community-Acquired Infections and Subsequent Risk of Chronic Lymphocytic Leukemia. British Journal of Haematology, 147, 444-449. https://doi.org/10.1111/j.1365-2141.2009.07849.x
Doody, M.M., Linet, M.S., Glass, A.G., Friedman, G.D., Pottern, L.M., Boice, J.D., et al. (1992) Leukemia, Lymphoma, and Multiple Myeloma Following Selected Medical Conditions. Cancer Causes Control, 3, 449-456. https://doi.org/10.1007/BF00051358
Ragozzino, M.W., Melton, L.J., Kurland, L.T., Chu, C.P. and Perry, H.O. (1982) Risk of Cancer after Herpes Zoster: A Population-Based Study. The New England Journal of Medicine, 307, 393-397. https://doi.org/10.1056/NEJM198208123070701
Fueyo, M.A. and Lookingbill, D.P. (1984) Herpes Zoster and Occult Malignancy. Journal of the American Academy of Dermatology, 11, 480-482. https://doi.org/10.1016/S0190-9622(84)70195-2
Buntinx, F., Wachana, R., Bartholomeeusen, S., Sweldens, K. and Geys, H. (2005) Is Herpes Zoster a Marker for Occult or Subsequent Malignancy? British Journal of General Practice, 55, 102-107.
Wang, Y.P., Liu, C.J., Hu, Y.W., Chen, T.J., Lin, Y.T. and Fung, C.P. (2012) Risk of Cancer among Patients with Herpes Zoster Infection: A Population-Based Study. CMAJ, 184, E804-E809. https://doi.org/10.1503/cmaj.120518
Iglar, K., Kopp, A. and Glazier, R.H. (2013) Herpes Zoster as a Marker of Underlying Malignancy. Open Medicine, 7, e68-e73.
Kurlan, J.G., Connelly, B.L. and Lucky, A.W. (2004) Herpes Zoster in the First Year of Life Following Postnatal Exposure to Varicella-Zoster Virus: Four Case Reports and a Review of Infantile Herpes Zoster. Archives of Dermatology, 140, 1268-1272. https://doi.org/10.1001/archderm.140.10.1268
Prabhu, S., Sripathi, H., Gupta, S. and Prabhu, M. (2009) Childhood Herpes Zoster: A Clustering of Ten Cases. Indian Journal of Dermatology, 54, 62-64. https://doi.org/10.4103/0019-5154.48991
Katakam, B.K., Kiran, G. and Kumar, U. (2016) A Prospective Study of Herpes Zoster in Children. Indian Journal of Dermatology, 61, 534-539. https://doi.org/10.4103/0019-5154.190121
Janniger, C.K., Eastern, J.S., Hopenthal, D.R., et al Herpes Zoster Updated March 6 2018, E-Medicine Article.
Bhushan, P., Sardana, K. and Mahajan, S. (2005) Dermatomal Vesicular Eruption in an Asymptomatic Infant. Dermatology Online Journal, 11, 26.
Solomon, A.R. (1988) New Diagnostic Tests for Herpes Simplex and Varicella Zoster Infection. Journal of the American Academy of Dermatology, 18, 218-221. https://doi.org/10.1016/S0190-9622(88)70032-8
Wu, C.L., Marsh, A. and Dworkin, R.H. (2000) The Role of Sympathetic Nerve Blocks in Herpes Zoster and Postherpetic Neuralgia. Pain, 87, 121-129. https://doi.org/10.1016/S0304-3959(00)00230-X
Dworkin, R.H., Perkins, F.M. and Nagasako, E.M. (2000) Prospects for the Prevention of Postherpetic Neuralgia in Herpes Zoster Patients. The Clinical Journal of Pain, 16, S90-S100. https://doi.org/10.1097/00002508-200006001-00016
Morton, P. and Thomson, A.N. (1989) Oral Acyclovir in the Treatment of Herpes Zoster in General Practice. New Zealand Medical Journal, 102, 93-95.
Wood, M.J., Kay, R., Dworkin, R.H., Soong, S.-J. and Whitley, R.J. (1996) Oral Acyclovir Therapy Accelerates Pain Resolution in Patients with Herpes Zoster: A Meta-Analysis of Placebo-Controlled Trials. Clinical Infectious Diseases, 22, 341-347. https://doi.org/10.1093/clinids/22.2.341
Beutner, K.R., Friedman, D.J., Forszpaniak, C., Andersen, P.L. and Wood, M.J. (1995) Valaciclovir Compared with Acyclovir for Improved Therapy for Herpes Zoster in Immunocompetent Adults. Antimicrobial Agents and Chemotherapy, 39, 1546-1553. https://doi.org/10.1128/AAC.39.7.1546
Tyring, S., Barbarash, R.A., Nahlik, J.E., et al. (1995) Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial. Annals of Internal Medicine, 123, 89-96. https://doi.org/10.7326/0003-4819-123-2-199507150-00002
Tyring, S.K., Beutner, K.R., Tucker, B.A., Anderson, W.C. and Crooks, R.J. (2000) Antiviral Therapy for Herpes Zoster: Randomized, Controlled Clinical Trial of Valacyclovir and Famciclovir Therapy in Immunocompetent Patients 50 Years and Older. Archives of Family Medicine, 9, 863-869. https://doi.org/10.1001/archfami.9.9.863
Glesby, M.J., Moore, R.D. and Chaisson, R.E. (1995) Clinical Spectrum of Herpes Zoster in Adults Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases, 21, 370-375. https://doi.org/10.1093/clinids/21.2.370
Gnann, J.W., Crumpacker, C.S., Lalezari, J.P., et al. (1998) Sorivudine versus Acyclovir for Treatment of Dermatomal Herpes Zoster in Human Immunodeficiency Virus-Infected Patients: Results from a Randomized, Controlled Clinical Trial. Antimicrobial Agents and Chemotherapy, 42, 1139-1145.
Safrin, S., Berger, T.G., Gilson, I., Wolfe, P.R. and Wofsy, C.B. (1991) Foscarnet Therapy in Five Patients with AIDS and Acyclovir-Resistant Varicella-Zoster Virus Infection. Annals of Internal Medicine, 115, 19-21. https://doi.org/10.7326/0003-4819-115-1-19
Whitley, R.J., Weiss, H., Gnann, J.W., et al. (1996) Acyclovir with and without Prednisone for the Treatment of Herpes Zoster: A Randomized, Placebo-Controlled Trial. Annals of Internal Medicine; 125, 376-383. https://doi.org/10.7326/0003-4819-125-5-199609010-00004
Bernstein, J.E., Korman, N.J., Bickers, D.R., Dahl, M.V. and Millikan, L.E. (1989) Topical Capsaicin Treatment of Chronic Postherpetic Neuralgia. Journal of the American Academy of Dermatology, 21, 265-270. https://doi.org/10.1016/S0190-9622(89)70171-7
Galer, B.S., Rowbotham, M.C., Perander, J. and Friedman, E. (1999) Topical Lidocaine Patch Relieves Postherpetic Neuralgia More Effectively than a Vehicle Topical Patch: Results of an Enriched Enrollment Study. Pain, 80, 533-538. https://doi.org/10.1016/S0304-3959(98)00244-9
Kanazi, G.E., Johnson, R.W. and Dworkin, R.H. (2000) Treatment of Postherpetic Neuralgia: An Update. Drugs, 59, 1113-1126. https://doi.org/10.2165/00003495-200059050-00007
Kotani, N., Kushikata, T., Hashimoto, H., et al. (2000) Intrathecal Methylprednisolone for Intractable Postherpetic Neuralgia. The New England Journal of Medicine, 343, 1514-1519. https://doi.org/10.1056/NEJM200011233432102
Davies, S.J., Harding, L.M. and Baranowski, A.P. (2002) A Novel Treatment of Post-Herpetic Neuralgia Using Peppermint Oil. The Clinical Journal of Pain, 18, 200-202. https://doi.org/10.1097/00002508-200205000-00011
Greenway, F.L., Frome, B.M., Engels, T.M. and McLellan, A. (2003) Temporary Relief of Post-Herpetic Neuralgia Pain with Topical Geranium Oil. The American Journal of Medicine, 115, 586-587. https://doi.org/10.1016/S0002-9343(03)00434-0
Sklar, S.H., Blue, W.T., Alexander, E.J. and Bodian, C.A. (1985) Herpes Zoster: The Treatment and Prevention of Neuralgia with Adenosine Monophosphate. JAMA, 253, 1427-1430. https://doi.org/10.1001/jama.1985.03350340079021
Friesen, K.J., Chateau, D., Falk, J., Alessi-Severini, S. and Bugden, S. (2017) Cost of Shingles: Population Based Burden of Disease Analysis of Herpes Zoster and Postherpetic Neuralgia. BMC Infectious Diseases, 17, 69. https://doi.org/10.1186/s12879-017-2185-3
Warren-Gash, C., Forbes, H. and Breuer, J. (2017) Varicella and Herpes Zoster Vaccine Development: Lessons Learned. Expert Review of Vaccines, 16, 1191-1201. https://doi.org/10.1080/14760584.2017.1394843
Sinéad, M.L., Smeeth, L., Margolis, D.J. and Thoma, S.L. (2013) Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-Herpetic Neuralgia in an Older US Population: A Cohort Study. PLOS Medicine, 10, e1001420. https://doi.org/10.1371/journal.pmed.1001420
Levin, M.J., Barber, D., Goldblatt, E., et al. (1998) Use of a Live Attenuated Varicella Vaccine to Boost Varicella-Specific Immune Responses in Seropositive People 55 Years of Age and Older: Duration of Booster Effect. The Journal of Infectious Diseases, 178, S109-S112. https://doi.org/10.1086/514264